热门资讯> 正文
Lexaria任命理查德·克里斯托弗为首席执行官
2024-09-05 22:49
- Lexaria Bioscience Corp Warrant 2020-12.01.26 on Lexaria Bioscience(LEXXW) 0
- Lexaria Bioscience Corp Ordinary Shares(LEXX) 0
- Lexaria Bioscience (NASDAQ:LEXX) on Thursday said Chief Executive Officer Chris Bunka is stepping aside for the appointment of Richard Christopher as new CEO, effective August 31, 2024.
- Most recently, Christopher was the CFO at InVivo Therapeutics. Prior to joining InVivo, Christopher was the CFO of iCAD.
- LEXX is +0.87% to $3.4701.
- Source: Press Release
More on Lexaria Bioscience Corp.
- Seeking Alpha’s Quant Rating on Lexaria Bioscience Corp.
- Historical earnings data for Lexaria Bioscience Corp.
- Financial information for Lexaria Bioscience Corp.
推荐文章
风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。
